Results 181 to 190 of about 92,786 (217)

Left ventricular diverticulum with hypertrophy of the left ventricular apex

The Annals of Thoracic Surgery, 1992
A surgical case of diverticulum in the left ventricular apex is presented. A two-dimensional echocardiogram and magnetic resonance image showed a calcified tumor buried in the marked hypertrophied apex of the left ventricle. Enucleation of the oval and hard tumor (4 x 2.5 x 2.5 cm) was performed through the apex, and the defect was anastomosed by ...
Chojiro Yamashita, Hiroomi Nakamura, Toshihiro Koterazawa, Sinnichirou Yamamoto, Satoshi Tobe   +4 more
openaire   +3 more sources

Management of the patient with left ventricular hypertrophy

European Heart Journal, 1993
The management of left ventricular hypertrophy (LVH) presupposes that the patient is identified by echocardiography and is carefully evaluated for risk stratification, taking into consideration possible associated complications. The role of non-pharmacological treatment is limited, except in obese patients.
O. d. Divitiis, A. Celentano, G. D. Simone, DI SOMMA, Salvatore, M. Galderisi, V. Liguori, M. d. Divitiis, M. Petitto   +7 more
openaire   +6 more sources

Left Ventricular Hypertrophy

AMA Guides® Newsletter, 2014
Abstract The fourth, fifth, and sixth editions of the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) use left ventricular hypertrophy (LVH) as a variable to determine impairment caused by hypertensive disease. The issue of LVH, as assessed echocardiographically, is a prime example of medical science being at odds with legal ...
openaire   +2 more sources

Ischaemia and left ventricular hypertrophy

European Heart Journal, 1993
Left ventricular hypertrophy (LVH), diagnosed by ECG and echocardiography, is commonly associated with coronary heart disease. Hypertensive patients with LVH and myocardial ischaemia may be at particular risk. The prevalence of ischaemia in hypertensive LVH was addressed in THAMES (Tenormin in Hypertension and Myocardial Ischaemia Epidemiological ...
openaire   +2 more sources

The Impact of Paricalcitol on Left Ventricular Hypertrophy

2011
Cardiovascular (CV) morbidity and mortality are significantly higher in patients with chronic kidney disease (CKD). Mineral metabolism disorders, such as hyperphosphatemia, hypocalcemia, and vitamin D deficiency, have been deeply associated not only with bone disease, but also with vascular calcification and CV disease.
Cozzolino M, Ronco C
openaire   +5 more sources

Left ventricular hypertrophy

2009
Abstract
openaire   +1 more source

Left Ventricular Hypertrophy in Hypertension [PDF]

Heart Drug, 2002
Because of the importance of left ventricular (LV) hypertrophy (LVH) as a strong independent risk factor for adverse cardiovascular events, clinical trials of the treatment of hypertension have recently focused on the efficacy of antihypertensive agents to decrease LV mass.
openaire   +1 more source

Left Ventricular Hypertrophy

2004
Left ventricular hypertrophy (LVH) is a common pathologic finding, occurring in about 20% of a population of 50-year-olds, and more in older people. It represents an independent predictor of premature death that is as important as frequent ventricular premature beats.
openaire   +2 more sources

Hypertension and left ventricular hypertrophy

Journal of Hypertension
In the initial stage, left ventricular hypertrophy (LVH) is adaptive, but in time, it transforms to maladaptive LVH which is specific for the development of various phenotypes that cause heart failure, initially with preserved, but later with reduced left ventricular ejection fraction.
Dragan B, Đorđević, Goran P, Koračević, Aleksandar D, Đorđević, Dragan B, Lović   +3 more
openaire   +2 more sources

Microcirculation and left-ventricular hypertrophy

Journal of Hypertension, 2012
F. Angeli, REBOLDI, Gianpaolo, P. Verdecchia   +2 more
openaire   +3 more sources